Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2

Oscar Zaragoza, Bettina C. Fries, Arturo Casadevall

Research output: Contribution to journalArticle

Abstract

The pathogenic fungus Cryptococcus neoformans has a polysaccharide capsule that is essential for virulence in vivo. Capsule size is known to increase during animal infection, and this phenomenon was recently associated with virulence. Although various conditions have been implicated in promoting capsule growth, including CO2 concentration, osmolarity, and phenotypic switching, it is difficult to reproduce the capsule enlargement effect in the laboratory. In this study, we report that serum can induce capsule growth, and we describe the conditions that induce this effect, not only by serum but also by CO2. Capsule enlargement was dependent on the medium used, and this determined whether the strain responded to serum or CO2 efficiently. Serum was most effective in inducing capsule growth under nutrient-limited conditions. There was considerable variability between strains in their response to either serum or CO2, with some strains requiring both stimuli. Sera from several animal sources were each highly efficient in inducing capsule growth. The cyclic AMP (cAMP) pathway and Ras1 were both necessary for serum-induced capsule growth. The lack of induction in the ras1 mutant was not complemented by exogenous cAMP, indicating that these pathways act in parallel. However, both cAMP and Ras1 were dispensable for inducing a partial capsule growth by CO2, suggesting that multiple pathways participate in this process. The ability of serum to induce capsule growth suggests a mechanism for the capsular enlargement observed during animal infection.

Original languageEnglish (US)
Pages (from-to)6155-6164
Number of pages10
JournalInfection and Immunity
Volume71
Issue number11
DOIs
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Cryptococcus neoformans
Capsules
Growth
Serum
Cyclic AMP
Virulence
Infection
Osmolar Concentration
Polysaccharides
Fungi

ASJC Scopus subject areas

  • Immunology

Cite this

Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2 . / Zaragoza, Oscar; Fries, Bettina C.; Casadevall, Arturo.

In: Infection and Immunity, Vol. 71, No. 11, 11.2003, p. 6155-6164.

Research output: Contribution to journalArticle

@article{0b60026181fa43509c01b0ff7f8d6ac8,
title = "Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2",
abstract = "The pathogenic fungus Cryptococcus neoformans has a polysaccharide capsule that is essential for virulence in vivo. Capsule size is known to increase during animal infection, and this phenomenon was recently associated with virulence. Although various conditions have been implicated in promoting capsule growth, including CO2 concentration, osmolarity, and phenotypic switching, it is difficult to reproduce the capsule enlargement effect in the laboratory. In this study, we report that serum can induce capsule growth, and we describe the conditions that induce this effect, not only by serum but also by CO2. Capsule enlargement was dependent on the medium used, and this determined whether the strain responded to serum or CO2 efficiently. Serum was most effective in inducing capsule growth under nutrient-limited conditions. There was considerable variability between strains in their response to either serum or CO2, with some strains requiring both stimuli. Sera from several animal sources were each highly efficient in inducing capsule growth. The cyclic AMP (cAMP) pathway and Ras1 were both necessary for serum-induced capsule growth. The lack of induction in the ras1 mutant was not complemented by exogenous cAMP, indicating that these pathways act in parallel. However, both cAMP and Ras1 were dispensable for inducing a partial capsule growth by CO2, suggesting that multiple pathways participate in this process. The ability of serum to induce capsule growth suggests a mechanism for the capsular enlargement observed during animal infection.",
author = "Oscar Zaragoza and Fries, {Bettina C.} and Arturo Casadevall",
year = "2003",
month = "11",
doi = "10.1128/IAI.71.11.6155-6164.2003",
language = "English (US)",
volume = "71",
pages = "6155--6164",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2

AU - Zaragoza, Oscar

AU - Fries, Bettina C.

AU - Casadevall, Arturo

PY - 2003/11

Y1 - 2003/11

N2 - The pathogenic fungus Cryptococcus neoformans has a polysaccharide capsule that is essential for virulence in vivo. Capsule size is known to increase during animal infection, and this phenomenon was recently associated with virulence. Although various conditions have been implicated in promoting capsule growth, including CO2 concentration, osmolarity, and phenotypic switching, it is difficult to reproduce the capsule enlargement effect in the laboratory. In this study, we report that serum can induce capsule growth, and we describe the conditions that induce this effect, not only by serum but also by CO2. Capsule enlargement was dependent on the medium used, and this determined whether the strain responded to serum or CO2 efficiently. Serum was most effective in inducing capsule growth under nutrient-limited conditions. There was considerable variability between strains in their response to either serum or CO2, with some strains requiring both stimuli. Sera from several animal sources were each highly efficient in inducing capsule growth. The cyclic AMP (cAMP) pathway and Ras1 were both necessary for serum-induced capsule growth. The lack of induction in the ras1 mutant was not complemented by exogenous cAMP, indicating that these pathways act in parallel. However, both cAMP and Ras1 were dispensable for inducing a partial capsule growth by CO2, suggesting that multiple pathways participate in this process. The ability of serum to induce capsule growth suggests a mechanism for the capsular enlargement observed during animal infection.

AB - The pathogenic fungus Cryptococcus neoformans has a polysaccharide capsule that is essential for virulence in vivo. Capsule size is known to increase during animal infection, and this phenomenon was recently associated with virulence. Although various conditions have been implicated in promoting capsule growth, including CO2 concentration, osmolarity, and phenotypic switching, it is difficult to reproduce the capsule enlargement effect in the laboratory. In this study, we report that serum can induce capsule growth, and we describe the conditions that induce this effect, not only by serum but also by CO2. Capsule enlargement was dependent on the medium used, and this determined whether the strain responded to serum or CO2 efficiently. Serum was most effective in inducing capsule growth under nutrient-limited conditions. There was considerable variability between strains in their response to either serum or CO2, with some strains requiring both stimuli. Sera from several animal sources were each highly efficient in inducing capsule growth. The cyclic AMP (cAMP) pathway and Ras1 were both necessary for serum-induced capsule growth. The lack of induction in the ras1 mutant was not complemented by exogenous cAMP, indicating that these pathways act in parallel. However, both cAMP and Ras1 were dispensable for inducing a partial capsule growth by CO2, suggesting that multiple pathways participate in this process. The ability of serum to induce capsule growth suggests a mechanism for the capsular enlargement observed during animal infection.

UR - http://www.scopus.com/inward/record.url?scp=0242381236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242381236&partnerID=8YFLogxK

U2 - 10.1128/IAI.71.11.6155-6164.2003

DO - 10.1128/IAI.71.11.6155-6164.2003

M3 - Article

C2 - 14573631

AN - SCOPUS:0242381236

VL - 71

SP - 6155

EP - 6164

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 11

ER -